Dr. Rimawi walks through DB-09’s three-arm blueprint; T-DXd solo, T-DXd + pertuzumab, and CLEOPATRA’s THP control and explains why dual blockade still matters early in metastatic disease.
DESTINY-Breast09 and the Three Arms in Two Minutes
Recommended Videos
